4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy has been researched along with acetylcysteine in 1 studies
Studies (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Trials (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Recent Studies (post-2010) (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
---|---|---|---|---|---|
8 | 0 | 5 | 14,580 | 1,046 | 5,960 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Guo, L; Guo, X; Liu, F; Mei, N; Ren, Z; Zhang, Z | 1 |
1 other study(ies) available for 4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy and acetylcysteine
Article | Year |
---|---|
ROS generation and JNK activation contribute to 4-methoxy-TEMPO-induced cytotoxicity, autophagy, and DNA damage in HepG2 cells.
Topics: Acetylcysteine; Anthracenes; Autophagy; Comet Assay; Cyclic N-Oxides; DNA Damage; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Oxidative Stress; Reactive Oxygen Species | 2018 |